Grimaldi Claudia's Form 4 filing
IGC Pharma, Inc. (IGC) · filed Jul 1, 2026
- Accession no.
- 0001185185-26-002764
- Filed
- Jul 1, 2026, 9:00 AM ET
- Trade date
- Jun 30, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Grimaldi ClaudiaCIK 0001745853 | Director, Officer (PFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | AGrant or awardAcquired | +2,048,378 | $0.27 | +$553,062.06 | 3,421,092 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.